Paysign (NASDAQ:PAYS) Releases Earnings Results, Misses Estimates By $0.02 EPS

Key Points

• Paysign reported earnings of $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.04 EPS by $0.02.
• The stock saw a 0.6% decline during midday trading, reaching a price of $7.12 with a market capitalization of $386.05 million.
• Insider selling activity included CFO and CEO transactions, with the CFO selling 30,396 shares and the CEO selling 62,158 shares, indicating a decrease in their ownership percentages.

Paysign (NASDAQ:PAYS - Get Free Report) issued its earnings results on Tuesday. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.02), Zacks reports. Paysign had a return on equity of 19.49% and a net margin of 9.55%. Paysign updated its Q3 2025 guidance to EPS and its FY 2025 guidance to 0.100-0.120 EPS.

Paysign Trading Down 0.6%

PAYS stock traded down $0.04 during midday trading on Tuesday, hitting $7.12. The company had a trading volume of 1,191,767 shares, compared to its average volume of 467,414. Paysign has a 52 week low of $1.80 and a 52 week high of $8.88. The stock's 50 day moving average price is $6.53 and its 200 day moving average price is $3.96. The stock has a market cap of $386.05 million, a price-to-earnings ratio of 64.73 and a beta of 0.78.

Insider Transactions at Paysign

In related news, CFO Jeffery Bradford Baker sold 30,396 shares of the company's stock in a transaction that occurred on Monday, August 4th. The stock was sold at an average price of $7.09, for a total transaction of $215,507.64. Following the completion of the transaction, the chief financial officer owned 252,273 shares in the company, valued at $1,788,615.57. This represents a 10.75% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Mark Newcomer sold 62,158 shares of the stock in a transaction on Monday, August 4th. The stock was sold at an average price of $7.09, for a total value of $440,700.22. Following the completion of the sale, the chief executive officer directly owned 8,750,728 shares in the company, valued at approximately $62,042,661.52. This represents a 0.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 433,602 shares of company stock valued at $2,409,455. Insiders own 22.40% of the company's stock.

Institutional Investors Weigh In On Paysign

Several hedge funds have recently made changes to their positions in the company. Goldman Sachs Group Inc. boosted its position in Paysign by 7.3% during the first quarter. Goldman Sachs Group Inc. now owns 258,334 shares of the company's stock worth $548,000 after purchasing an additional 17,466 shares in the last quarter. Rhumbline Advisers grew its stake in shares of Paysign by 5.2% in the first quarter. Rhumbline Advisers now owns 46,587 shares of the company's stock valued at $99,000 after buying an additional 2,303 shares in the last quarter. Finally, Jane Street Group LLC purchased a new position in Paysign in the first quarter valued at $51,000. 25.89% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

PAYS has been the subject of several analyst reports. DA Davidson set a $8.00 target price on Paysign in a research note on Friday, June 13th. Lake Street Capital raised their target price on Paysign from $7.00 to $9.00 and gave the stock a "buy" rating in a research note on Thursday, June 26th. Finally, LADENBURG THALM/SH SH raised their target price on Paysign from $7.25 to $8.25 and gave the stock a "buy" rating in a research note on Friday, May 9th.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.